Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-21-000874
Filing Date
2021-06-14
Accepted
2021-06-14 19:13:02
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 e620712_4-duane.html 4  
1 e620712_4-duane.xml 4 3829
  Complete submission text file 0001193805-21-000874.txt   5253
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VITAL THERAPIES, INC. 15010 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address
Nash Duane (Reporting) CIK: 0001591098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 211016206